BioXcel Therapeutics, Inc.
BTAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $17 | $31 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $1 | $1 | $1 |
| Other Curr. Assets | $7 | $7 | $6 | $7 |
| Total Curr. Assets | $44 | $25 | $38 | $37 |
| Property Plant & Equip (Net) | $0 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45 | $26 | $39 | $38 |
| Liabilities | – | – | – | – |
| Payables | $16 | $17 | $15 | $16 |
| Short-Term Debt | $17 | $11 | $6 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $5 | $4 | $6 |
| Total Curr. Liab. | $38 | $33 | $26 | $22 |
| LT Debt | $92 | $97 | $100 | $103 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $3 | $3 | $7 |
| Total NC Liab. | $96 | $100 | $103 | $109 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $134 | $133 | $129 | $131 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$708 | -$677 | -$657 | -$650 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $619 | $569 | $567 | $557 |
| Total Equity | -$89 | -$108 | -$90 | -$93 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $26 | $39 | $38 |
| Net Debt | $72 | $92 | $75 | $73 |